The relationship between cardiovascular disease and survival in patients having cardiac avoidance radiotherapy for lung cancer
Overall survival was poorer in patients with cardiac comorbidity than in those without, particularly among those receiving a higher CAA dose, while absolute survival estimates suggested a clinically meaningful benefit of lower CAA dose among patients with pre-existing CVD, supporting the potential importance of CAA minimisation in this higher-risk group.